Abbott to Spin Off Global Nutrition Unit via Tax-Free Distribution by End of 2027
ABT sits 23% above its 52-week low of $81.97.
Summary
Abbott plans to split off its Global Nutrition business, an $8.5B unit, into a separate publicly traded company, structured as a tax-free distribution to shareholders, with completion targeted by the end of 2027. The company expects one-time charges before the separation and says the combined dividend will match Abbott's dividend at the time of the split. Management explicitly said the move will not affect 2026 guidance or the 2027 guidance it plans to give in January, and it reaffirmed its FY26 adjusted EPS outlook while cutting its 2026 sales growth view. After the separation, Abbott retains a $42B healthcare portfolio. This is a major portfolio reshaping for a company of Abbott's size — Nutrition is a large, slower-growth segment, and separating it leaves a more device- and diagnostics-focused Abbott. The tax-free structure and dividend continuity reduce the near-term disruption for holders. Watch the January 2027 guidance, which will be the first formal look at the standalone Abbott financials.
At the time of this announcement, ABT was trading at $100.55 on NYSE in the Life Sciences sector, with a market capitalization of approximately $177.3B. The 52-week trading range was $81.97 to $132.03. This news item was assessed with neutral market sentiment and an importance score of 9 out of 10. Source: Reuters.